MyFinsight
Home
About
Contact
rgnx: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, RGNX has $525,203K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
525,203
581,027
Total stockholders equity
161,452
213,679
Total liabilities and stockholders equity
525,203
581,027
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Total property and
equipment
$191,054K
Other current assets
$19,472K
Prepaid expenses
$12,943K
Accounts receivable
$25,347K
Marketable securities
$215,403K
Cash and cash
equivalents
$58,802K
Other assets
$4,268K
Restricted cash
$2,030K
Operating lease
right-of-use assets
$48,820K
Property and equipment,
net
$107,515K
Accounts receivable
$2,765K
Marketable securities
$27,838K
Total current assets
$331,967K
Accumulated depreciation
and amortization
$83,539K
Total assets
$525,203K
Total liabilities and
stockholders equity
$525,203K
Total stockholders
equity
$161,452K
Total liabilities
$363,751K
Accumulated deficit
-$1,058,878K
Accumulated other
comprehensive loss
-$652K
Additional paid-in capital
$1,220,977K
Other liabilities
$648K
Royalty monetization
liabilities
$149,916K
Operating lease
liabilities
$67,433K
Deferred revenue
$21,186K
Total current
liabilities
$124,568K
Common stock 0.0001 par
value 100,000 shares...
$5K
Royalty monetization
liabilities
$41,718K
Operating lease
liabilities
$9,073K
Deferred revenue
$13,195K
Accrued expenses and
other current...
$38,316K
Accounts payable
$22,266K
Subscribe for Financial Insights
REGENXBIO Inc. (RGNX)
REGENXBIO Inc. (RGNX)